基本信息
浏览量:4
职业迁徙
个人简介
During her PhD and subsequent post doctoral research, Dr Pericleous worked primarily on antiphospholipid autoantibodies (aPL), the serological hallmark for APS and an independent risk factor for CVD in SLE. Of all autoantibody families, aPL are the best characterised for their ability to induce a procoagulant, proinflammatory and oxidative endothelial phenotype. However, the molecular mechanisms that underpin these aPL-mediated changes to endothelial function are ill-defined. In SLE, other autoantibody families could also contribute to CVD, but this area remains largely unexplored. Dr Pericleous' fellowship focuses on delineating the intracellular molecular basis of autoantibody-mediated endothelial dysfunction in order to improve our understanding of vasculopathy in APS and SLE, with the ultimate aim of identifying novel therapeutic targets to modulate dysfunction in patients with systemic autoimmune diseases.
研究兴趣
论文共 145 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
medrxiv(2024)
medrxiv(2024)
crossref(2024)
crossref(2024)
EUROPEAN RESPIRATORY JOURNAL (2023)
ARTHRITIS & RHEUMATOLOGY (2023): 45-47
引用0浏览0引用
0
0
C. Pericleous, R. Maughan, L. Kabir, A. Dabrowska,K. Paschalaki,D. Carling,A. Randi,D. Arachchillage, J. Mason
ANNALS OF THE RHEUMATIC DISEASES (2023): 1061-1062
加载更多
作者统计
#Papers: 145
#Citation: 1796
H-Index: 23
G-Index: 39
Sociability: 7
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn